Skip to main content
. 2019 Mar 9;8(2):155–170. doi: 10.1007/s40121-019-0239-0

Table 1.

In vitro activities of plazomicin and comparators against resistant isolates [1116]

Species AG MIC50 (mg/L) MIC90 (mg/L) MIC range
All Enterobacteriaceae Plazomicin 0.5 1 0.25 to 8
AMKa 8 64 1 to > 64
GENb 32  > 64 0.5 to > 64
TOBc 32  > 32 0.5 to > 32
Escherichia coli Plazomicin 0.5 1 0.5 to 4
AMK  < 8  > 32  < 8 to 32
GEN 8  > 8  < 2 to 8
TOB 32  > 32 1 to 32
Enterobacter spp. Plazomicin 0.5 1  < 0.5 to 16
AMK 8 64  < 1 to > 64
GEN 32  > 64  < 1 to > 64
TOB 0.5 64 0.5 to 64
Klebsiella pneumoniae Plazomicin 0.5 1 0.25 to 8
AMK 32  > 32  < 8 to 32
GEN 4 8  < 2 to 8
TOB 32  > 32 0.5 to 64
Pseudomonas aeruginosa Plazomicin 8 64 0.5 to > 64
AMK 16  > 64 1 to > 64
GEN  > 64  > 64 8 to > 64
TOB 2 16 0.5 to > 64
Acinetobacter spp. Plazomicin 16 32 1 to > 64
AMK  > 64  > 64 4 to > 64
GEN  > 64  > 64 2 to > 64
TOB  > 64  > 64 2 to 64
Methicillin-resistant Staphylococcus aureus Plazomicin 1 2 0.25 to 4
AMK 16  > 64 0.5 to > 64
GEN 32  > 64 0.25 to > 64
TOB

aAMK amikacin

bGEN gentamicin

cTOB tobramycin